Yamouchi Korea grew 25% of sales and 59% of net income.

Published: 2004-06-15 06:56:00

Updated: 2004-06-15 06:56:00

Yamanouchi Korea reported the FY2003 business performance (11th fiscal year) recording 27,022 million won of sales, about 25.07% up from the previous year, 7,943 million won of operation income, 58.44% up, 7,985 million won of ordinary income, about 2,800 million won of increase over the previous...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK